The impact of epicardial collateral use on the outcomes of retrograde chronic total occlusion percutaneous coronary intervention
Recommended Citation
Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Martinez-Parachini JR, Tajti P, Kandzari DE, Krestyaninov O, Jaber W, Choi J, Rangan BV, Ungi I, Banerjee S, and Brilakis ES. The impact of epicardial collateral use on the outcomes of retrograde chronic total occlusion percutaneous coronary intervention. Eur Heart J 2019; 40:87.
Document Type
Conference Proceeding
Publication Date
12-2019
Publication Title
Eur Heart J
Abstract
Background: The impact of the type of collateral vessel used on the outcomes of retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. Methods: We reviewed the baseline clinical and angiographic characteristics and procedural outcomes of 1,501 retrograde CTO PCIs performed in 1494 patients between 2012 and 2019 at 26 centres. Purpose: We sought to examine the impact of the type of collateral vessel used on the outcomes of retrograde CTO PCI. Results: Mean patient age was 65.0±10 years and 86% were men. Septal collaterals or bypass grafts were used in 66%, epicardial collaterals in 34% of lesions. Compared with cases in which only septal collaterals and bypass grafts were used, use of epicardial collaterals were associated with larger vessel diameter (3.0 [2.5; 3.0] vs. 3.0 [2.5, 3.2] mm, p=0.005), more moderate/severe tortuosity (55% vs. 42%, p<0.0001), more moderate/ severe calcification (73% vs. 65%, p=0.002), and higher Japan chronic total occlusion score (3.34±1.02 vs. 3.11±1.07, p<0.0001). Epicardial collateral use was associated with lower technical (76.3% vs. 80.6%, p=0.053) and procedural (71.9% vs. 77.8%, p=0.011) success rates, but similar incidence of major cardiac adverse events (4.72% vs. 4.56%, p=0.889). Epicardial collaterals were associated with more perforations (10.63% vs. 7.30%, p=0.028). Epicardial collateral use was associated with longer fluoroscopy time (82 [64, 104] 76 [(55, 102] p=0.0003) and higher contrast volume (300 [221; 414] ml vs. 270 [200; 370] ml, p<0.0001). Conclusion: In a contemporary, multicenter registry epicardial collaterals were used in approximately one-third of retrograde CTO PCIs. Use of epicardial collaterals was associated with lower success but similar major complication rates.
Volume
2019
Issue
40
First Page
87
